miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17

Published:2022-12-24 Issue: Volume: Page:
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Liu Junhong,Ye Lin,Lin Kangqiang,Zhong Tieshan,Luo Jiguang,Wang Tao,Suo Liya,Mo Qingrong,Li Shuqun,Chen Qian,Yu Yaqun^ORCID

Funder

Natural Science Foundation of Guangxi Province

Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11010-022-04617-8.pdf

Reference48 articles.

1. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS (2018) Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 24:4846–4861. https://doi.org/10.3748/wjg.v24.i43.4846

2. Tempero MA (2019) NCCN guidelines updates: pancreatic cancer. J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007

3. Yadav D, Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144:1252–1261. https://doi.org/10.1053/j.gastro.2013.01.068

4. Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH (2018) Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol 15:333–348. https://doi.org/10.1038/s41575-018-0005-x

5. Gupta R, Amanam I, Chung V (2017) Current and future therapies for advanced pancreatic cancer. J Surg Oncol 116:25–34. https://doi.org/10.1002/jso.24623

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncoding Ribonucleic Acids (RNAs) May Improve Response to Immunotherapy in Pancreatic Cancer;ACS Pharmacology & Translational Science;2024-08-07

2. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches;Cancer Letters;2024-04

3. Circular RNAs in pancreatic cancer progression;Clinica Chimica Acta;2024-01

4. MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives;Current Opinion in Rheumatology;2023-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3